The Common PAR4 Ala120Thr Variant Has a Major Effect on Platelet Reactivity to Thrombin and These Effects Are Enhanced with PAR1 and P2Y12 Inhibition

被引：0
|
作者：
Whitley, Michael J. [1 ,2 ]
Vesci, Joanne [3 ,4 ]
Holinstat, Michael [5 ,6 ]
Edelstein, Leonard C. [7 ,8 ]
Bray, Paul F. [9 ,10 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Med, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
[5] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[7] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
[8] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[9] Thomas Jefferson Univ, SidneyKimmel Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
[10] Thomas Jefferson Univ, SidneyKimmel Med Coll, Dept Med, Philadelphia, PA 19107 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.709.709
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
709
引用
收藏
页数：5
相关论文
共 13 条
  • [1] PAR4 Ala120Thr Variant Alters PAR4 Desensitization, Sensitivity to Platelet Antagonists and Risk of Large Vessel Stroke
    Whitley, Michael
    Henke, David
    Simon, Lukas
    Vesci, Joanne
    Holinstat, Michael
    Nieman, Marvin
    Shaw, Chad
    Bray, Paul
    Edelstein, Leonard
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [2] Frequency of PAR4 Ala120Thr variant associated with platelet reactivity significantly varies across sub-Saharan African populations
    Heenkenda, Menikae K.
    Lindahl, Tomas L.
    Osman, Abdimajid
    BLOOD, 2018, 132 (19) : 2103 - 2106
  • [3] PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation
    Holinstat, Michael
    Voss, Bryan
    Bilodeau, Matthew L.
    McLaughlin, Joseph N.
    Cleator, John
    Hamm, Heidi E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (36) : 26665 - 26674
  • [4] P2Y12 antagonsim provides more effective inhibition of platelet responses to thrombin than PAR-1 or PAR-4 antagonism
    Ofosu, F.
    Nkonge, K.
    Chong, M.
    Jakubowski, J.
    Sugidachi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 530 - 531
  • [5] The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition
    Whitley, M. J.
    Henke, D. M.
    Ghazi, A.
    Nieman, M.
    Stoller, M.
    Simon, L. M.
    Chen, E.
    Vesci, J.
    Holinstat, M.
    McKenzie, S. E.
    Shaw, C. A.
    Edelstein, L. C.
    Bray, P. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (12) : 2501 - 2514
  • [6] The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation
    Wu, Chin-Chung
    Wu, Shih-Yun
    Liao, Chieh-Yu
    Teng, Che-Ming
    Wu, Yang-Chang
    Kuo, Sheng-Chu
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (03) : 643 - 658
  • [7] Platelet reactivity in response to P2Y12, thromboxane, and PAR1 agonists among patients with acute ischemic stroke and large vessel occlusion
    Bender, Matthew T.
    Bhalla, Tarun
    Mattingly, Thomas
    Cameron, Scott J.
    Morrell, Craig
    VASCULAR MEDICINE, 2020, 25 (03) : NP30 - NP30
  • [8] ;Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1-and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA
    Kamada, Asami
    Shimizu, Mie
    Oura, Kazumasa
    Yoshida, Makiko
    Tsuda, Keisuke
    Oi, Kiyotaka
    Ishigaku, Yoko
    Natori, Tatsunori
    Narumi, Shinsuke
    Itabashi, Ryo
    Maeda, Tetsuya
    Terayama, Yasuo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (03):
  • [9] Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation
    Shakhidzhanov, S. S.
    Shaturny, Vi
    Panteleev, Ma.
    Sveshnikoya, A. N.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2015, 1850 (12): : 2518 - 2529
  • [10] Residual platelet activation through protease-activated receptors (PAR)-1 and-4 in patients on P2Y12 inhibitors
    Eslam, Roza Badr
    Lang, Irene M.
    Koppensteiner, Renate
    Calatzis, Andreas
    Panzer, Simon
    Gremmel, Thomas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 403 - 406
12